Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

Core Viewpoint - Sunshine Biopharma Inc. has approved a strategic investment of $5 million in Bitcoin as a reserve asset, aiming to strengthen its financial foundation while advancing its drug pipeline [1] Financial Strategy - The investment in Bitcoin is part of a broader strategy to enhance the company's financial stability [1] - The company is focusing on developing generic prescription drugs and proprietary mRNA-based cancer therapies and antiviral drug candidates [1]